| Treatment Group | Percentage of Total Cell Population (%) | Treatment Effect Group | ||
---|---|---|---|---|---|
R1 | C | 11.08 | A | Â | Â |
 | TPO | 8.10 | A | B |  |
 | L | 8.04 | A | B |  |
 | APS + L | 7.83 | A | B |  |
 | APS | 7.61 | A | B |  |
 | N | 5.75 |  | B |  |
R2 | C | 33.84 | A | Â | Â |
 | L | 28.01 | A |  |  |
 | APS + L | 26.95 | A | B |  |
 | TPO | 17.84 |  | B | C |
 | APS | 17.06 |  | B | C |
 | N | 11.42 |  |  | C |
R1+R2 | C | 44.91 | A | Â | Â |
 | L | 36.05 | A | B |  |
 | APS + L | 34.78 | A | B |  |
 | TPO | 25.94 |  | B | C |
 | APS | 24.68 |  | B | C |
 | N | 17.17 |  |  | C |